A dynamic COVID-19 immune signature includes associations with poor prognosis

Laing, Adam G., Lorenc, Anna, del Molino del Barrio, Irene, Das, Abhishek, Fish, Matthew, Monin, Leticia, Muñoz-Ruiz, Miguel, McKenzie, Duncan R. +42 more·2020·Nature Medicine
DOI 10.1038/s41591-020-1038-6

Cited by (953)

Items 801–900 of 953

  1. Humoral response to SARS-CoV-2 after vaccination and booster effect in patients undergoing dialysis
    M. Hernández-Porto, Sagrario García, T. Delgado, Yaiza Rodriguez, A. Aguirre-Jaime, S. Campos, Cintia Hernández, C. Lorenzo, M. Lecuona · 2022 · International Journal of Infectious Diseases
  2. The Impact of Maternal SARS-CoV-2 Infection Next to Pre-Immunization with Gam-COVID-Vac (Sputnik V) Vaccine on the 1-Day-Neonate’s Blood Plasma Small Non-Coding RNA Profile: A Pilot Study
    Angelika V. Timofeeva, Ivan S. Fedorov, Vitaliy Chagovets, V.V. Zubkov, Макиева Мзия Ильинична, Сугак Анна Борисовна, Франкевич Владимир Евгеньевич, Gennadiy Tikhonovich Sukhikh · 2022 · COVID
  3. Tracing the cell-type-specific modules of immune responses during COVID-19 progression using scDisProcema
    Anyao Li, Jihong Yang, Jingyang Qian, Xin Shao, Jie Liao, Xiaoyan Lu, Xiaohui Fan · 2022 · Computational and Structural Biotechnology Journal
  4. Shedding Light on Immunological Research in Lyon, France. IRCI2022 Brings the Scientific World to Lyon and Bridges the Latest Immunological Findings in Cancer and Infection
    Lucie Fallone, Guilhem Lalle, Manuela Pereira-Abrantes, Emily Sible, Marie‐Cécile Michallet, Bao Q. Vuong, Uzma Ayesha Hasan · 2022 · The Journal of Immunology
  5. Neural epidermal growth factor-like 1 protein variant increases survival and modulates the inflammatory and immune responses in human ACE-2 transgenic mice infected with SARS-CoV-2
    Roopa Biswas, Shannon S. Eaker, Dharmendra Kumar Soni, Swagata Kar, Denae N. LoBato, Cymbeline T. Culiat · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  6. Immunological Subpopulations Within Critically Ill COVID-19 Patients
    Julie Wilson, Manu Shankar‐Hari · 2021 · CHEST Journal
  7. Distinct immune responses in patients infected with influenza or SARS-CoV-2, and in COVID-19 survivors, characterised by transcriptomic and cellular abundance differences in blood
    Jelmer Legebeke, Jenny Lord, Rebekah Penrice-Randal, Andrés F. Vallejo, Stephen Poole, Nathan James Brendish, Xiaofeng Dong, Catherine S. Hartley, John W. Holloway, Jane S. Lucas et al. · 2021 · medRxiv
  8. Pre-existing and post-COVID-19 immune responses to SARS-CoV-2 in cancer patients
    Tatjana Bilich, Malte Roerden, Yacine Maringer, Annika Nelde, Jonas S. Heitmann, Marissa Lisa Dubbelaar, Andreas Peter, Sebastian Hörber, Jens Bauer, Jonas Rieth et al. · 2021 · Research Square
  9. Conventional and unconventional T cell responses contribute to the prediction of clinical outcome and causative bacterial pathogen in sepsis patients
    Ross J. Burton, Loïc Raffray, Linda Moet, Simone M. Cuff, Daniel Allan White, Sarah E. Baker, Bernhard Moser, Valerie B. O’Donnell, Peter Ghazal, Matt P. G. Morgan et al. · 2023 · medRxiv
  10. A 3D Printed Ventilated Perfused Lung Model Platform to Dissect the Lung’s Response to Viral Infection in the Presence of Respiration
    İrem Deniz Derman, Mecit Altan Alioglu, Dishary Banerjee, Sarah E. Holton, Danielle Nicole Klunk, Momoka Nagamine, Syed Hasan Askari Rizvi, Carmen R. Mikacenic, Nazmiye Celik, Diana Cadena Castaneda et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  11. Cross-platform comparison of highly-sensitive immunoassays for inflammatory markers in a COVID-19 cohort 1
    Koji Abe, Joanne C. Beer, Tran Thuy Nguyen, Ishara S. Ariyapala, Tyson H. Holmes, Wei Feng, Bingqing Zhang, Dwight Kuo, Yuling Luo, Xiao-Jun Ma et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  12. SARS-CoV-2 infection elucidates unique features of pregnancy-specific immunity
    Dong Sun Oh, Eunha Kim, Guangqing Lu, Rachelly Normand, Lydia L. Shook, Amanda E. Lyall, Olyvia J. Jasset, Stepan Demidkin, Emily Gilbert, Joon Mee Kim et al. · 2024 · medRxiv
  13. Network-based multi-omics-disease-drug associations reveal drug repurposing candidates for COVID-19 disease phases
    Francis Edem Agamah, Thomas H. A. Ederveen, Michelle Skelton, Darren Patrick Martin, Emile Rugamika Chimusa, Peter A.C. 't Hoen 't Hoen · 2024
  14. Implications of SARS‐CoV‐2 Immunity in the Context of the Pathogenesis of COVID‐19, Immune Evasion of the Virus, and the Effectiveness of Vaccination
    Hikmet Akkız · 2024 · Preprints.org
  15. Polyunsaturated fatty acid-derived lipid mediator networks characterize COVID-19 severity and risk for critical illness
    Maria E. Papadaki, Eleftherios Pavlos, Marc Dubourdeau, Vincent Bailif, Kamal Badirou, Ioanna E. Galani, Dimitris Papelis, Natalia Kamperi, Vasiliki Triantafyllia, Lena Siouti et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  16. Citizen science gamers enable automated flow cytometry gating through machine learning
    Sebastiano Montante, Daniel Yokosawa, Leon Li, Alexander Butyaev, Mehrnoush Malek, Razzi Movassaghi, Quentin Michalchuk, Chieh-Ting Hsu, David Shmil, Albina Rahim et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  17. Reply: From mice to humans: basophil-driven resolution in ARDS
    Seiko Takasawa, Hajime Karasuyama, Kensuke Miyake, Yasunari Miyazaki · 2025 · European Respiratory Journal
  18. Reply to Sanfilippo et al. and to Caviedes et al.
    Deepa J. Arachchillage, Sujal R. Desai, Anand Devaraj, Carole A. Ridge, Simon P.G. Padley, Brijesh V. Patel · 2020 · American Journal of Respiratory and Critical Care Medicine
  19. A model of endemic coronavirus infections
    David S. Huen · 2020 · medRxiv
  20. Inmunoterapia en la prevención y el manejo de la COVID-19: pros y contras de una carrera contra el tiempo
    Universidad de San Martín de Porres, Leonor Ríos, Joel de León, Universidad de San Martín de Porres · 2020 · Revista de Investigaciones de la Universidad Le Cordon Bleu
  21. Host metabolite-cytokine correlation landscape in SARS-CoV-2 infection
    Nan Xiao, Meng Nie, Huanhuan Pang, Bohong Wang, Jieli Hu, Xiangjun Meng, Ke Li, Xiaorong Ran, Quanxin Long, Haijun Deng et al. · 2020 · Research Square
  22. Mass Cytometry and Artificial Intelligence Define CD169 as a Marker of SARS-CoV2-Induced Acute Respiratory Distress Syndrome
    Mikaël Roussel, Juliette Ferrant, Florian Reizine, Simon Le Gallou, Joëlle Dulong, Sarah H. Carl, Mathieu Lesouhaitier, Murielle Grégoire, Nadège Bescher, Clothilde Verdy et al. · 2020 · SSRN Electronic Journal
  23. Report of the British Society for Cardiovascular Research Inaugural Online Autumn Meeting 2020
    Helen M. Arthur · 2021 · Cardiovascular Drugs and Therapy
  24. Coronavirus-associated molecular mimicry through homology to a SARS-CoV-2 peptide could be leading to susceptibility in patients with HLA-A*02:01 and HLA-A*24:02 serotypes
    Yekbun Adıgüzel · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  25. Network-based integration of epigenetic landscapes unveils molecular programs underlying human T follicular helper cell differentiation
    Vinay S. Mahajan, Syed Ashiqur Rahman, Vinay Viswanadham, Grace J. Yuen, Na Sun, Hamid Mattoo, Shiv S Pillai, Jishnu Das · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  26. Therapeutic Strategies for Novel Corona Virus Disease (COVID-19): A Comprehensive Review
    Manoj Manikrao Gadewar, Mohd Kafeel, Dharmender · 2021 · Acta Scientific Pharmaceutical Sciences
  27. Predicting Progression to Severe COVID-19 Using the PAINT Score Based on Natural Killer Cells
    Ming Wang, Dongbo Wu, Changhai Liu, Yan Li, Jianghong Hu, Wei Wang, Wei Jiang, Qifan Zhang, Zhixin L. Huang, Lang Bai et al. · 2021 · Research Square
  28. Targeting Mononuclear Phagocytes to Treat COVID-19
    Brandt D. Pence, T. Cory · 2021 · IntechOpen eBooks
  29. The Evolution of COVID-19: A Minimal Invasive Autopsy Cohort Studying in Depth the Different COVID- 19 Disease Stages
    Valentino D’Onofrio, L. Z. van Keulen, Annelore Vandendriessche, Jasperina Dubois, Reinoud Cartuyvels, Marie-Elena Vanden Abeele, Judith Fraussen, Patrick Vandormael, Veerle A Somers, Ruth Achten et al. · 2021 · Research Square
  30. Integrated immune networks in SARS-CoV-2 infected pregnant women reveal differential NK cell and unconventional T cell activation
    Katherine Kedzierska, Jennifer R. Habel, Brendon Yew Loong Chua, Łukasz Kedzierski, Kevin John Selva, Timon Damelang, Ebene R. Haycroft, Thi H. O. Nguyen, Hui‐Fern Koay, Suellen R Nicholson et al. · 2021 · Research Square
  31. Management of Hospitalized Adult Patients with Coronavirus 2019 (COVID-19): A Therapeutic Guideline
    Pir Hossien Kolivand, Vahid Dehestani, Hadi Kazemi · 2021 · The Neuroscience Journal of Shefaye Khatam
  32. Immunotherapy in the Treatment of COVID-19
    Малкова Анна Михайловна, Anna Andreevna Starshinova, I. V. Kudryavtsev, I. F. Dovgalyuk, Yulia S. Zinchenko, Dmitry Anatolievich Kudlay · 2021 · Pediatric Hematology/Oncology and Immunopathology
  33. Neutrophil Extracellular Traps, Local IL-8 Expression, and Cytotoxic T-Lymphocyte Absence in the Lungs of Fatal COVID-19: A Retrospective Histopathology Cohort Study
    Ignacio Melero, María Villalba-Esparza, Borja Recalde Zamacona, Álvaro Teijeira, Allan Argueta, Laura García‐Tobar, Laura Álvarez-Gigli, Cristina Sainz, David García-Ros, Estefanía Toledo et al. · 2021 · SSRN Electronic Journal
  34. CELL-BASED THERAPY FOR MS PATIENTS DURING COVID-19 PANDEMIC PRACTICAL RECOMMENDATIONS FOR CLINICAL TRIALS
    Seyedmassood Nabavi · 2021 · Journal of Clinical Trials
  35. La ética de la autenticidad en el nuevo marco cultural: pensando a Taylor
    Sabio Esquíroz, Ma Pilar · 2014 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  36. C 4 H 6 O, C 4 H 6 S与XF (X＝F, Cl, Br)分子间卤键的电子密度拓扑研究
    曾艳丽, 吉丽婷, 郑世钧, 孟令鹏 · 2011 · 化学学报
  37. Inflammatory Biomarkers and Chronic Diseases: The Link to COVID-19.
    2021
  38. The risk of COVID-19 can be predicted by a nomogram based on the m6A-related gene
    Lingling Lu, Xiulan Ao, Yijing Li, Jiaofeng Huang, Bang Liu, Liqing Wu, Dongliang Li · 2022 · Research Square
  39. Integrated immune networks in SARS-CoV-2 infected pregnant women reveal differential NK cell and unconventional T cell activation
    Jennifer R. Habel, Brendon Yew Loong Chua, Łukasz Kedzierski, Kevin John Selva, Timon Damelang, Ebene R. Haycroft, Thi H. O. Nguyen, Hui‐Fern Koay, Suellen R Nicholson, Hayley A. McQuilten et al. · 2021 · medRxiv
  40. S100A9 as an inflammatory marker in hospitalized COVID-19 patients
    Larissa Gomes Barbosa, Artur Christian Garcia da Silva, Juliana Marques Oliveira, Mary Hellen Fabres Klein, Raphael Contelli Klein, Larissa Paola Rodrigues Venâncio, Théo Araújo-Santos, Pedro C. de Souza, Jonilson Berlink Lima · 2022 · Research Square
  41. Correlation of the TCR Diversity Indexes in the Peripheral Blood with Disease Susceptibility and Deterioration in COVID-19 Patients
    Yue Zhuo, Jiyuan Zhang, Zhen Zhang, Lifeng Zhang, Xin Yang, Jin‐Wen Song, Xuan Zhao, Jianmin Huang, Xing Fan, Ping Shuai et al. · 2022 · SSRN Electronic Journal
  42. Correlation between thymic output and disease severity in critically ill COVID-19 patients: extended abstract
    Amira Marouf, Pelagia Cuvelier, Hélène Roux, Anne Couëdel-Courteille, Jacques Dutrieux, Cécile Naudin, Bénédicte Charmeteau-De Muylder, Rémi Cheynier, Pierre Squara, Stéfano Marullo · 2022 · Mediastinum
  43. Evaluation of Hematologic Parameters in Patients with COVID-19 Following Mesenchymal Stem Cell Therapy
    Haniye Bakhshi, Masoud Soleimani, Mina Soufi Zomorrod, Omid Kooshkaki · 2022 · DNA and Cell Biology
  44. Analysis of differences in lymphocyte subsets and CD4+ T cells immune activation between re-detectable positive and non-re-detectable positive COVID-19 convalescent patients
    Zhimin Huang, Guilian Li, Zhengrong Yang, Lin Zhou, Min Jiang, Hao Li, Yifan Zhong, Yixiang Jiang, Xiaohui Wang, Taiping He · 2022 · Research Square
  45. Prognostic Value of Inflammatory Biomarkers in COVID-19
    KOUAM Tasnim KOUAM Tasnim, Abdelkhaled Ilias, Ammor Abdesselam, Hanane Khalki · 2022 · Scholars International Journal of Traditional and Complementary Medicine
  46. Obesity is associated with a distinct innate immune phenotype in severe COVID-19 patients
    Ayane de Sá Resende, Yrna Lorena de Oliveira, Mariana Nobre Farias de Franca, Cristiane Bani Correa, Kiyoshi F. Fukutani, Michael W. Lipscomb, Tatiana de Moura · 2022 · Research Square
  47. Multivariate indicators of disease severity in COVID-19
    Wail M. Hassan, Joe Bean, Leticia Kuri-Cervantes, Michael Pennella, Michael R. Betts, Nuala J. Meyer · 2022 · Research Square
  48. The landscape of lung microbiota predicts the outcome of severe community-acquired pneumonia by interacting with the host immune response
    Yi Han, Mengna Lin, Feixiang Xu, Keyu Sun, Bin Yang, Su Lu, Hailin Ding, Jianli Wang, Guorong Gu, Min Min et al. · 2022 · Research Square
  49. Research Article SARS-CoV-2 genetic and immunology insights: what does the scientific community know so far?
    M. Cabrera, Marcela Salazar-Viedma, Vivían D’Afonseca · 2022 · Genetics and Molecular Research
  50. Impacts of viral pathogenesis and vaccine immunization on the host humoral immune response in SARS-CoV-2 and associated variants of concern (VOCs) infection
    Sougata Roy Chowdhury, Subhendu Chakrabarty, Modhurima Chakraborti, Amlan Kumar Das · 2023 · Elsevier eBooks
  51. Innate immune responses in COVID-19
    Etienne D. Jacotot, Laura Talamini, Srinivasa Reddy Bonam, Angelica Thomas Vieira, Véronique Frémeaux‐Bacchi, Marko Z. Radic, Marie‐Agnès Dragon‐Durey, José Manuel Lozano, Rafael Simone Saia, Sylviane Muller · 2023 · Elsevier eBooks
  52. Integrated analyses of single-cell RNA-seq public data reveal the gene regulatory network landscape of respiratory epithelial and peripheral immune cells in COVID-19 patients
    Lin Zhang, Hafumi Nishi, Kengo Kinoshita · 2023 · medRxiv
  53. Nanomedicine Applied to Inflammatory and Infectious Pulmonary Diseases
    Arshdeep Kaur, Rishika Sharma, Isaac Kirubakaran Sundar, Gopinath Packirisamy · 2023 · Interdisciplinary biotechnological advances
  54. Can Fetuin-A Deficiency Predict the Severity of COVID-19 Disease in Kidney Transplant Recipients?
    Musa Pinar, Hamad Dheir, Aysel Gürkan Toçoğlu, Hande Toptan, Taner Demirci, Selçuk Yaylacı, Gözde Çakırsoy Çakar, Necattin Fırat, Emrah Akın, Mahmud İslam et al. · 2023 · Transplantation Proceedings
  55. Data from Preexisting and Post–COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
    Tatjana Bilich, Malte Roerden, Yacine Maringer, Annika Nelde, Jonas S. Heitmann, Marissa Lisa Dubbelaar, Andreas Peter, Sebastian Hörber, Jens Bauer, Jonas Rieth et al. · 2023
  56. Immunology of COVID-19
    Robert S. Wallis, Amit K. Srivastava, Andreas Wack, Charles A Knirsch · 2023 · Elsevier eBooks
  57. Analisis Faktor-Faktor yang Mempengaruhi Gangguan Perilaku dan Fungsi Kognitif di Masa Pandemi COVID-19 Pada Pasien Poliklinik Neurologi RSUD dr. Zainoel Abidin
    Ika Marlia X, X Suherman, Fitria Armalivia · 2023 · Journal of Medical Science
  58. Immune signature of patients with cardiovascular disease – in-depth immunophenotyping predicts increased risk for a severe course of COVID-19
    Manina Günter, Karin Anne Lydia Mueller, Mathew J. Salazar, Sarah Gekeler, Carolin Prang, Tobias Harm, Meinrad Gawaz, Stella E. Autenrieth · 2023 · medRxiv
  59. Characterization of Murine Lymphocyte Activation and Exhaustion Markers by a 14-Color Flow Cytometry Panel
    Daniel C Rose, Annah S. Rolig, William L. Redmond · 2023 · Bioanalysis
  60. Inmunología en el diagnóstico, patogénesis, tratamiento y prevención por las vacunas contra el COVID-19
    Aldina Maria Prado Barral, Manoel Barral‐Netto · 2023 · Revista de estudios brasileños
  61. FEATURES OF THE INNATE IMMUNE RESPONSE DURING THE SARS-COV-2 INFECTION
    Tanja Džopalić, Milica Veljković, Marko Bjelaković, Branislav Jovanović · 2023 · Acta Medica Medianae
  62. An Experimental Realization of Coronavirus Crisis for Certain Countries: Through a Novel SEQIAR-D-Based Mathematical Model
    Muhammad Sinan, Jinsong Leng, Awais Ahmed, Faiza Hasin, Jehan Akbar, Abdul Abdul, Jingfu Bao · 2023 · SSRN Electronic Journal
  63. Immunological sub-phenotypes and response to Convalescent Plasma in COVID-19 induced ARDS: a secondary analysis of the CONFIDENT trial.
    Benoît Misset, Anh Nguyet Diep, Axelle Bertrand, Michaël Piagnerelli, Eric A. J. Hoste, Isabelle Michaux, Elisabeth De Waele, Alexander Dumoulin, Philippe G. Jorens, Emmanuel van der Hauwaert et al. · 2024 · Research Square
  64. Prevalência e reatividade cruzada entre SARS-CoV-2 e HCoVs endêmicos
    Ariane Cesario Lima · 2023 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  65. The influence of comorbid diseases on the profiles of signaling biomarkers (macrophage-derived chemokine, interferon-γ-induced protein 10 kD, soluble CD40 ligand, vascular endothelial growth factor) and severity in patients with COVID-19: clinical studies
    Anna Yu. Anisenkova, Mazurov Vi, Светлана Вячеславовна Апалько, Олег Сергеевич Попов, Сушенцева Наталья Николаевна, Ольга Петровна Мамаева, Sergey V. Mosenko, Аndrey М. Sarana, Sergey G. Shcherbak · 2023 · HERALD of North-Western State Medical University named after I I Mechnikov
  66. Perspectives on Molecular Mimicry Between Human, SARS-CoV-2, and Plasmodium Species Through a Probabilistic and Evolutionary Insight
    Yekbun Adıgüzel, Yehuda Shoenfeld · 2024 · Elsevier eBooks
  67. Circulating TNF-RII, IP-10 and HGF are associated with severity of COVID-19 in oncologic patients
    Jaime Carrillo, Serena Lacerenza, Nadia Hindi, David S. Moura, Gloria Marquina, Daniel Parra Corral, Jennifer Olalla, Juana María Cano, Sergio Hoyos, Marta Renshaw et al. · 2024 · Cytokine
  68. Assessment of longitudinal changes in immune responses in critically ill adults with COVID-19
    Jennifer Rynne, Matthew Fish, Aislinn Jennings, Peter Smith, Mia Mosavie, Carolyn Lam, Sarah Kelly, Barnaby Sanderson, Gill Arbane, Gianluca Lucchese et al. · 2024 · Research Square
  69. Additional file 2 of Gut microbiome alterations and gut barrier dysfunction are associated with host immune homeostasis in COVID-19 patients
    Zhonghan Sun, Song, Zhi-Gang, Chenglin Liu, Shishang Tan, Shuchun Lin, Jiajun Zhu, Fahui Dai, Jian Gao, Jia-Lei She, Zhendong Mei et al. · 2022 · Figshare
  70. Additional file 3 of Human endogenous retrovirus K in the respiratory tract is associated with COVID-19 physiopathology
    Jairo Ramos Temerozo, Natalia Fintelman Rodrigues, Monique Cristina dos Santos, Eugênio Damaceno Hottz, Carolina Q. Sacramento, Aline de Paula Dias da Silva, Samuel Coelho Mandacaru, Emilly Caroline dos Santos Moraes, Monique R. O. Trugilho, João Silveira Moledo Gesto et al. · 2022 · Figshare
  71. Additional file 4 of Human endogenous retrovirus K in the respiratory tract is associated with COVID-19 physiopathology
    Jairo Ramos Temerozo, Natalia Fintelman Rodrigues, Monique Cristina dos Santos, Eugênio Damaceno Hottz, Carolina Q. Sacramento, Aline de Paula Dias da Silva, Samuel Coelho Mandacaru, Emilly Caroline dos Santos Moraes, Monique R. O. Trugilho, João Silveira Moledo Gesto et al. · 2022 · Figshare
  72. Identification of immune cell infiltration and biomarkers in Alzheimer's disease and COVID-19 by integrated bioinformatics analysis and machine learning
    Juntu Li, Linfeng Tao, Yanyou Zhou, Yue Zhu, Chao Li, Yiyuan Pan, Jun Liu · 2024 · Research Square
  73. Contribución de las células T de memoria en la generación de inmunidad de larga duración contra COVID-19
    Alejandro Torres-Flores, Isabel Wong‐Baeza, Constantino III Roberto López-Macías · 2024 · Gaceta Médica de México
  74. IP10 levels refine severity prognostication in COVID-19 and implicate causes of clinical deterioration: lessons for pandemic preparedness
    Abhishek Das, Jia Wei, Duncan R. McKenzie, Luke B. Snell, Shruthi Sasidharan, Pierre Vantourout, Iva Zlatareva, Blair Merrick, Benjamin Thomas, Vasista Adiga et al. · 2024 · medRxiv
  75. Immunoprofiling Reveals Disease-Associated Alterations of Eosinophils in Acute Mountain Sickness: A Cross-Sectional and Longitudinal Cohort Study
    Jingxuan Han, Jian Gao, Yanyun Ma, Yi Li, Chenyuan Wu, Shiguan Le, Yiran Zhao, Helian Li, Yali Luo, Xuling Han et al. · 2024 · SSRN Electronic Journal
  76. COVID-19 severity and nonalcoholic fatty liver disease
    Nina Vrsaljko, Branimir Gjurašin, Neven Papić · 2024 · Elsevier eBooks
  77. Recent infection with SARS ‐ CoV ‐2 in donors was associated with a higher incidence of acute graft‐versus‐host disease in recipients undergoing allogeneic haematopoietic stem cell transplantation
    Fan Lin, Lan‐Ping Xu, Ting‐Ting Han, Zhengli Xu, Jing Liu, Yun He, Yao Chen, Huan Chen, Wei Han, Yu‐Hong Chen et al. · 2024 · British Journal of Haematology
  78. Sepsis from SARS-COV2 Infection (COVID-19): Pathophysiology and Clinic of SARS-COV2 Infection and Sepsis
    Giorgio Tulli · 2024 · Springer eBooks
  79. Differential action modes of Neutrophil Extracellular Trap-targeted drugs define T cell responses in SARS-CoV-2 infection
    Caio Santos Bonilha, Flavio Protasio Veras, Anderson dos Santos Ramos, Giovanni Freitas Gomes, Robertha Mariana Rodrigues Lemes, Eurico Arruda, José Carlos Alves-Filho, Thiago M. Cunha, Fernando Q. Cunha · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  80. Identificação de vias de sinalização imunossupressoras associada à infecção por SARS-CoV-2 em células epiteliais nasofaríngeas de pacientes do sexo masculino e feminino
    André Luiz Caliari Costa · 2024
  81. Correlations of systemic blood cytokines in patients with coronary heart disease and experienced COVID-19
    V.V. Negrebetsky, Николай Михайлович Агарков, Диана Руслановна Шмарова · 2023 · Vrach
  82. Autoimmune disorders in patients with granulomatosis diseases after COVID-19: T- and B-cells subsets function
    Anna Andreevna Starshinova, Igor Vladimirovich Kudryavtsev, Artem Rubinstein, Малкова Анна Михайловна, Hong Ling, M. Zhuang, A. Yu. Starshinova, Irina Dovgaluk, Dmitry Anatolievich Kudlay · 2024 · Russian Journal of Infection and Immunity
  83. Contribution of memory T cells to the generation of long-lasting immunity against COVID-19
    Alejandro Torres-Flores, Isabel Wong‐Baeza, Constantino III Roberto López-Macías · 2024 · Gaceta Médica de México
  84. Exploring the Efficacy of Convalescent Plasma Therapy in COVID-19 Patients: A Clinical Trial Study
    Motahareh Mahi‐Birjand, Masood Ziaee, Effat Alemzadeh, Amin Barkhordari, Zohreh Azarkar, Azadeh Ebrahimzadeh, Farshid Abedi, Ghodsiyeh Azarkar · 2024 · Coronaviruses
  85. Immunological sub-phenotypes and response to convalescent plasma in COVID-19 induced ARDS: a secondary analysis of the CONFIDENT trial
    Benoît Misset, Anh Nguyet Diep, Axelle Bertrand, Michaël Piagnerelli, Eric A. J. Hoste, Isabelle Michaux, Elisabeth De Waele, Alexander Dumoulin, Philippe G. Jorens, Emmanuel van der Hauwaert et al. · 2024 · Annals of Intensive Care
  86. COVID-19 inflammatory signature in a Mozambican cohort: unchanged red blood series and reduced levels of IL-6 and other proinflammatory cytokines
    Vânia Maphossa, Onélia Guiliche, Teresa Babetine, Celso Castiano, Osvaldo Inlamea, Marino Marengue, Igor Paulo Ubisse Capitine, Lúcia Chambal, Almiro Rogério Tivane, Jahit Sacarlal et al. · 2024 · BMC Infectious Diseases
  87. Functional Status of different subsets of Dendritic cell and T cell in COVID-19: an immunological perspective
    Analava Bera, Kaustav Chakraborty, Arindam Bhattacharyya · 2020 · Journal of Applied Biochemistry & Laboratory Medicine
  88. Virus-specific T cell response in SARS-CoV-2 infection and vaccinations
    Antonio Bertoletti, Martin Qui, Joey Ming Er Lim · 2025 · Elsevier eBooks
  89. Clinical and Multiorgan Proteomics Characteristics of the Diverse Fatal Phase in Super Elderly Patients With SARS‐CoV‐2 Infection: A Descriptive Study
    Shuxia Wang, Jin Sun, Yazhuo Hu, Wei Zhang, Bangguo Qin, Man Li, Nan Zhang, Shengshu Wang, Tingyu Zhou, Miao Liu et al. · 2025 · Journal of Medical Virology
  90. Identification of Early Biomarkers of Mortality in COVID-19 Hospitalized Patients: A LASSO-Based Cox and Logistic Approach
    Anna Maria Fratta Pasini, Chiara Stranieri, Edoardo Giuseppe Di Leo, Lorenzo Bertolone, Antonino Aparo, Fabiana Busti, Annalisa Castagna, Alice Vianello, Fabio Chesini, Simonetta Friso et al. · 2025 · Viruses
  91. ICARus: a pipeline to extract robust gene expression signatures from transcriptome datasets
    Zhaorong Li, Juan I. Fuxman Bass · 2025 · Frontiers in Bioinformatics
  92. Immunology in Paediatric Intensive Care
    Michael James Carter, Jordi Miatello · 2025 · Springer eBooks
  93. Kinetics of anti-SARS-CoV-2 antibodies and hematological parameters in hospitalized pre-vaccination COVID-19 patients in Peru
    Salyoc Tapia-Rojas, Alexis Germán Murillo Carrasco, María J. Pons, Manuel Francisco Ugarte-Gil, Ana Mayanga-Herrera · 2025 · PeerJ
  94. Declining antibodies and immunity to COVID-19 – why the worry?
    Alexander N. Poltorak · 2020
  95. ¿Debemos preocuparnos ante la disminución de anticuerpos al recuperarnos del COVID-19?
    Alexander N. Poltorak · 2020
  96. Functional immune changes are conserved in COVID-19 and trauma patients receiving intensive care
    Alexander J. T. Wood, Gesa J. Albers, Willem Cornelissen, James D. Maiden, Deirdre E. Cuff, Mitra Ashayeripanah, Patrick Schriek, Samantha J. Emery‐Corbin, Nichollas E. Scott, Shihan Li et al. · 2026 · Nature Communications
  97. Optimizing clustering of CDR3 sequences using natural language processing, Word2Vec, and KMeans
    Sanskriti Baranwal, Ricardo Avila Sanchez, Clement-Andi Edet, Erick J. Chastain, Inimary T. Toby · 2025 · Frontiers in Bioinformatics
  98. Immune Cell Dysfunction of SARS-CoV-2: Mathematical Modeling of the Within-Host Immune Dynamics
    Pagnapech Ngoun, Nicolas Alvarez, Ayesh Awad, Hwayeon Ryu · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  99. Effect of thyme-ivy syrup on antiviral immune response in patients with mild COVID-19: a prospective, open-label, randomized pilot study
    Stephanie Dauth, S.M.G. Schäfer, Maximilian Klippstein, Ann Christina Foldenauer, Christin Jonetzko, Tanja Roßmanith, Susanne Schiffmann, Maria J. G. T. Vehreschild, Gerd Geißlinger, Frank Behrens et al. · 2025 · Frontiers in Medicine
  100. Immune responses in pulmonary sarcoidosis following COVID-19
    Anna Andreevna Starshinova, Igor Kudryavtsev, Artem Rubinstein, Tatiana Akisheva, А. С. Головкин, Zoia R. Korobova, Anastasia Kulpina, Dmitry Anatolievich Kudlay · 2025 · Frontiers in Immunology